Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Trends in Endocrinology   Volumes    Volume 4 
Further understanding the counter regulatory hormone (7-84 PTH) and PTH related diseases
Thomas L. Cantor, Hiroyuki Yamashita
Pages: 29 - 56
Number of pages: 28
Current Trends in Endocrinology
Volume 4 

Copyright © 2010 Research Trends. All rights reserved

In 1998, the research group led by Pierre D’Amour (University of Montreal) demonstrated that the intact PTH (iPTH) assay measures both  1-84 PTH and 7-84 PTH. In that same year, Cantor, et al. (antibody producer for iPTH assays) produced the first specific Whole 1-84 PTH (CAP™) Assay. Consequent study of the biological importance of 7-84 PTH yielded several discoveries such as:  7-84 PTH circulates in the blood of normals and patients with a range of 10:1 to 1:10 compared to 1-84 PTH; it is produced in the parathyroid glands and has a half life twice as long as 1-84 PTH; it is hypocalcemic, inhibits formation of osteoclasts, osteoblasts and bone resorption; has its own C-terminal receptor and physically binds to bone cells; it down regulates the PTH1/PTHrp receptor; lowers bone turnover and can cause adynamic bone disease (ABD); its levels are regulated by blood calcium; inhibit the secretion of 1-84 PTH and increase more rapidly than 1-84 PTH with decreasing kidney function; 7-84 PTH helps to predict bone status in ESRD and is 94% accurate in predicting bone status in the 1-84 PTH/7-84 PTH ratio (critical to forming treatment plans for African Americans); 7-84 PTH increases are associated with growth retardation in pediatric ESRD patients and affect the mortality rate of hemodialysis patients. The concentration variability and biological actions of 7-84 PTH explain why the iPTH assay is non-diagnostic of bone disease, may not reliably guide therapy, and explain Block, et al.’s findings that elevated iPTH indicates the lowest mortality risk.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms